SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-24-032067
Filing Date
2024-03-08
Accepted
2024-03-08 06:17:19
Documents
2
Period of Report
2024-02-29

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm248257-4_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm248257-4_3seq1.xml 3 1598
2 EXHIBIT 24 tm248257d4_ex24.htm EX-24 7030
  Complete submission text file 0001104659-24-032067.txt   10083
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address
TAGLIAFERRI MARY (Reporting) CIK: 0001323304 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38650 | Film No.: 24732271

Mailing Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169
Business Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169 212-847-9841
Y-mAbs Therapeutics, Inc. (Issuer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)